Malaysia Glaucoma Surgery Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Procedure, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Malaysia · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$2.1 MnPlaceholder estimate
Estimate 2025$2.3 Mn0.2% of the global market
Projected 2034$5.0 Mn 120.8%Adds $2.7 Mn over 9 forecast years
CAGR 2025–20349.2%Faster than 52% of 173 Medical Devices markets here
1 in MalaysiaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Malaysia. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Malaysia Glaucoma Surgery Devices Market Analysis Executive Summary
Glaucoma surgery devices lower eye pressure using tiny stents, shunts and lasers, often during cataract surgery.
Key segments of the glaucoma Surgery Devices market include product (MIGS Devices, Glaucoma Drainage Devices and Laser Systems) and procedure (Standalone and Combined with Cataract Surgery).
Malaysia Glaucoma Surgery Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Malaysia Glaucoma Surgery Devices Market Dynamics
Market Growth Drivers
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the glaucoma Surgery Devices market.
Opportunity
Longer-acting treatments, home-based care and screening in emerging markets give the glaucoma Surgery Devices market room to grow.
Market Restraints
High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the glaucoma Surgery Devices market.
Competitive Landscape for Glaucoma Surgery Devices Market in Malaysia
The glaucoma Surgery Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Glaucoma Surgery Devices Market in Malaysia
Glaucoma Surgery Devices in Malaysia: rules, payment and research
Medical devices must be registered with the Medical Device Authority (MDA) under the Medical Device Act 2012.[1] Public clinics and hospitals run by the Ministry of Health give heavily subsidised care.[2] ClinicalTrials.gov lists 1 study on Glaucoma Surgery Devices that is recruiting, active or about to start in Malaysia.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Malaysia. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how glaucoma Surgery Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Malaysia.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Product
4.2 By Procedure
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Glaukos
7.2 Alcon
7.3 Johnson & Johnson Vision
7.4 Sight Sciences
7.5 Ellex (Lumibird)
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The glaucoma Surgery Devices market can be segmented based on various criteria, including product, procedure and end user. Here's a breakdown of the market segmentation
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Glaucoma Surgery Devices right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Glaucoma Surgery Devices in context
Malaysia compared
Health spending per person: 450 US$ per person (2023). World: 1,317 US$ per person (2023). 6th highest of the 15 countries we cover in APAC.[1]
Doctors: 2.34 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 6th highest of the 15 countries we cover in APAC.[2]
People aged 65 and over: 8.0% of people (2025). World: 10.4% of people (2025). 8th highest of the 16 countries we cover in APAC.[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
How big is the Glaucoma Surgery Devices market in Malaysia?
Placeholder estimate: about $2.3 Mn in 2025, rising to about $5.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Glaucoma Surgery Devices market in Malaysia growing?
Placeholder estimate: about 9.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Glaucoma Surgery Devices market report cover?
The report splits the market by product (MIGS Devices, Glaucoma Drainage Devices, Laser Systems), procedure (Standalone, Combined with Cataract Surgery) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Glaucoma Surgery Devices market?
Key players include Glaukos, Alcon, Johnson & Johnson, Sight Sciences and Ellex (Lumibird).
What is driving the Glaucoma Surgery Devices market?
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the glaucoma Surgery Devices market.
Who regulates Glaucoma Surgery Devices in Malaysia?
Medical devices must be registered with the Medical Device Authority (MDA) under the Medical Device Act 2012. Source: Medical Device Authority. Checked 14 Nov 2026.
How is healthcare paid for in Malaysia?
Public clinics and hospitals run by the Ministry of Health give heavily subsidised care. Source: Ministry of Health Malaysia. Checked 14 Nov 2026.
How many clinical trials on Glaucoma Surgery Devices are running in Malaysia?
1 study is recruiting, active or about to start in Malaysia, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Malaysia. Retrieved 12 Nov 2026.
How much research is published on Glaucoma Surgery Devices?
PubMed lists 916 papers on Glaucoma Surgery Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Malaysia 
China
India
US
Canada
Japan
Germany
France
Brazil
Italy
UK
Ecuador
Spain
Saudi Arabia
Mexico
Russia
Australia
New Zealand
South Africa
UAE
Egypt
Philippines
Hong Kong
Thailand
Singapore
Kenya
AbbVie Inc.